Evidence map›Paper›PMID 31413095›Full record

Trial reportHaematologica2020

A cross-trial comparison of single-agent ibrutinib

Alessandra Tedeschi, Richard Greil, Fatih Demirkan, Tadeusz Robak, Carol Moreno, Paul M Barr, Bertrand Anz, David Simpson, Gianluca Gaidano, Osnat Bairey and 10 more

Abstract readLetterRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Haematologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alessandra TedeschiASST Grande Ospedale Metropolitano Niguarda, Milan, Italy alessandra.tedeschi@ospedaleniguarda.it.
Richard GreilParacelsus Medical University Salzburg, Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria.
Fatih DemirkanDokuz Eylul University, Izmir, Turkey.
Tadeusz RobakMedical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.
Carol MorenoHospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
Paul M BarrWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Bertrand AnzTennessee Oncology, Chattanooga, TN, USA.
David SimpsonNorth Shore Hospital, Auckland, New Zealand.
Gianluca GaidanoAmedeo Avogadro University of Eastern Piedmont, Novara, Italy.
Osnat BaireyRabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Don StevensNorton Cancer Institute, Louisville, KY, USA.
Devinder GillPrincess Alexandra Hospital, Brisbane, Australia.
Ian W FlinnSarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
Thomas J KippsUniversity of California, San Diego, Moores Cancer Center, La Jolla, CA, USA.
Jan A BurgerThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jennifer LinPharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
Thomas WebbJanssen Ltd, High Wycombe, UK.
Viktor FedorovPharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
Lori StylesPharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
John G GribbenBarts Cancer Institute, Queen Mary University of London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellAdenineAntibodies, Monoclonal, HumanizedChlorambucilHumansPiperidinesAdenineAntibodies, Monoclonal, HumanizedChlorambucilibrutinibobinutuzumabPiperidines

Identifiers

PMID31413095
PMCPMC7109731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.